Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

A Double-blind Randomized Controlled Trial to Assess the Lot-to-lot Consistency of Sci-B-Vac™ in Adults (CONSTANT)

Trial Profile

A Double-blind Randomized Controlled Trial to Assess the Lot-to-lot Consistency of Sci-B-Vac™ in Adults (CONSTANT)

Active, no longer recruiting
Phase of Trial: Phase III

Latest Information Update: 12 Dec 2018

At a glance

  • Drugs Hepatitis B vaccine recombinant (Primary)
  • Indications Hepatitis B
  • Focus Registrational; Therapeutic Use
  • Acronyms CONSTANT
  • Sponsors VBI Vaccines
  • Most Recent Events

    • 09 Nov 2018 Status changed from recruiting to active, no longer recruiting, according to a VBI Vaccines media release.
    • 09 Nov 2018 According to a VBI Vaccines media release, the last subject received the first vaccination in November 2018 in this trial.
    • 26 Jul 2018 According to a VBI Vaccines media release, topline data from this trial is expected in the second half of 2019.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top